Multidrug-resistant tuberculosis Infections and Infestations Tuberculosis
Conditions
Interventions
MDR TB patients who will have been randomly allocated to the intervention group will receive palliative care from palliative care specialist nurses who will receive a two days intensive integrated pal
follow up will be done once every week if a participant is still admitted on the ward and every two weeks if they are at home over the three months period of the study. However for every alternative w
Sponsors
King's College London
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 18 years and above 2. Diagnosis of MDR TB 3. Registered at the MDR TB clinic of the respective study sites 4. Willing to give informed consent
Exclusion criteria
Exclusion criteria: All MDR TB patients attending the respective study sites who are unable to memorize past events due to their impaired cognitive ability as judged by attending physicians and all those who cannot express themselves in English or local language will be excluded from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-reported palliative care-related symptoms and concerns (measured using the Integrated APCA African POS) at baseline and then monthly for 4 months | — |
Secondary
| Measure | Time frame |
|---|---|
| At baseline and then monthly for 4 months: 1. Quality of life assessed using GHQ-12 and the World Health Organization quality of life (WHOQOL - BREF) assessment tool 2. Social support assessed using MOS Social Support Survey 3. Adherence to treatment which will be measured during clinical assessment using the Adherence and Alcohol tool 4. Service use measured with Client Services Receipt Inventory (CSRI) | — |
Countries
Uganda
Outcome results
None listed